Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy

C Bret (1, 2, 3) , E Viziteu (1) , A Kassambara (1) , J Moreaux (2, 3, 1)

1 IGH - Institut de génétique humaine
2 UM1 - Université Montpellier 1
3 Department of Biological Haematology, CHU Montpellier, Montpellier, France

Domaines: Génétique

C Bret, E Viziteu, A Kassambara, J Moreaux. Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy. Expert Review of Hematology, 2016, 9 (4), pp.351-360. ⟨10.1586/17474086.2016.1141673⟩. ⟨hal-01299313⟩